Biogen
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Biogen - overview
Established
2005
Location
-, Bedfordshire, UK
Primary Industry
Biotechnology
About
Biogen is a UK-based company specializing in sustainable food waste management through anaerobic digestion, generating renewable energy and biofertiliser for agricultural use. Founded in 2005 in the UK, Biogen focuses on the processing of food waste to produce renewable energy. The company operates advanced processing facilities and has not undergone any significant business pivots or changes. Ruby Jones currently serves as the CEO.
Biogen specializes in the collection and processing of food waste from supermarkets, restaurants, manufacturers, and households. Their core service involves anaerobic digestion, converting organic matter into biogas for renewable energy generation. The nutrient-rich biofertiliser produced is returned to agricultural lands, and their clients primarily include local authorities and commercial organizations across the UK. In the most recent year of 2024, Biogen reported revenue of USD 39.
87 mn and an EBITDA of USD 5. 02 mn. Their revenue model relies on service agreements with municipalities and commercial clients, ensuring a predictable revenue stream tied to food waste processing and biogas generation.
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Website
http://www.biogen.co.uk/
Total Amount Raised
Subscriber access only
Biogen - timeline of key events
Biogen - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 6,599,837 | 8,042,180 | 9,133,000 | 15,858,000 | 16,101,000 | 20,735,000 | 18,936,000 | - | 23,324,000 | 20,710,000 | 20,022,000 | 18,904,000 | 22,441,000 | - | - | - |
| % Revenue Growth (YoY) | - | 21.9% | 13.6% | 73.6% | 1.5% | 28.8% | (8.7%) | - | - | - | (3.3%) | (5.6%) | 18.7% | - | - | - |
| EBITDA (USD) | (728,615) | (62,435) | 113,000 | 1,334,000 | 566,000 | (77,000) | (6,445,000) | - | 3,872,000 | 4,931,000 | 3,717,000 | 1,858,000 | 31,586,000 | - | - | - |
| Operating Income (USD) | (2,214,734) | (1,725,035) | (1,342,000) | 54,000 | (1,083,000) | (3,269,000) | (10,053,000) | - | 427,000 | 2,153,000 | 1,316,000 | (727,000) | 29,404,000 | - | - | - |
| Operating Margin | (33.6%) | (21.4%) | (14.7%) | 0.3% | (6.7%) | (15.8%) | (53.1%) | - | 1.8% | 10.4% | 6.6% | (3.8%) | 131.0% | - | - | - |
| % EBITDA Margin | (11.0%) | (0.8%) | 1.2% | 8.4% | 3.5% | (0.4%) | (34.0%) | - | 16.6% | 23.8% | 18.6% | 9.8% | 140.8% | - | - | - |
| NET Income (USD) | (2,887,235) | (1,823,558) | (1,239,000) | (304,000) | (1,517,000) | (4,438,000) | (11,734,000) | - | (1,516,000) | (161,000) | 552,000 | (4,329,000) | 27,500,000 | - | - | - |
| % Net Margin | (43.7%) | (22.7%) | (13.6%) | (1.9%) | (9.4%) | (21.4%) | (62.0%) | - | (6.5%) | (0.8%) | 2.8% | (22.9%) | 122.5% | - | - | - |
Biogen - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N/A | Completed | Tamar Energy | - | ||||||||
| Trade Sale | Completed | Halstead AD Facility | - | ||||||||
| Trade Sale | Completed | Holbeach Anaerobic Digestion Facility | - | ||||||||
| Trade Sale | Completed | Farleigh Anaerobic Digestion Facility | - | ||||||||
| Trade Sale | Completed | Retford Anaerobic Digestion Facility | - |
Displaying 1 - 5 of 7
Biogen - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.